Purpose: To evaluate the efficacy of the semiquantitative and quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiating between benign and malignant soft-tissue tumors. Methods: A total of 45 patients with pathologically confirmed soft-tissue tumors (15 benign and 30 malignant tumors) underwent DCE-MRI. The semiquantitative parameters assessed were as follows: time to peak (TTP), maximum concentration (MAX Conc), area under the curve of time-concentration curve (AUC-TC), and maximum rise slope (MAX Slope). Quantitative DCE-MRI was analyzed with the extended Tofts-Kety model to assess the following quantitative parameters: volume transfer constant (Ktrans), microvascular permeability reflux constant (Kep), and distribute volume per unit tissue volume (Ve). Data were evaluated using the independent t test or Mann-Whitney U test and receiver operating characteristic (ROC) curves. Results: The TTP (P ¼ .0035), MAX Conc
Introduction
Soft-tissue tumors represent a remarkably heterogeneous group of benign and malignant tumors. 1 The prognosis of patients with soft-tissue tumors depends on early diagnosis and subsequent adequate treatments. 2, 3 Benign and malignant soft-tissue tumors have distinct clinical treatments. Malignant soft-tissue tumors are primarily treated using surgical resection, whereas asymptomatic patients with benign soft-tissue tumors only require clinical observation. 3 A correct differential diagnosis of benign and malignant softtissue tumors is important to avoid unnecessary surgery; however, the rarity of soft-tissue tumors, together with the overlapping radiological appearances, render an accurate differential diagnosis challenging. 1 The conventional diagnostic examinations of soft-tissue tumors are primarily based on traditional characterizations on medical images involving the location, size, morphology, and surrounding structure of the lesions. However, the traditional imaging characteristics of many soft-tissue tumors are not diagnostic. Conventional enhanced magnetic resonance imaging (MRI) can reflect only one or several specific times of enhancement, which does not allow clinicians to quantitatively distinguish between benign and malignant soft-tissue lesions. More importantly, conventional diagnostic examinations rely on the subjective judgment of radiologists and lack objective parameters.
Dynamic contrast-enhanced MRI (DCE-MRI) is a particularly attractive method as it can provide morphological information of soft-tissue tumors and enable monitoring of dynamic changes in the enhanced characteristics of a lesion. 4, 5 The DCE-MRI technique can provide superior information about the function of a tissue and provide more important information on tissue perfusion, vasculature, capillary permeability, and interstitial space volume. 6, 7 Dynamic contrast-enhanced MRI has been used in cases of breast cancer, 8, 9 glioma, 10, 11 and prostate cancer. 12, 13 However, to the best of our knowledge, only a few reports have described the value of DCE-MRI in the differential diagnosis of soft-tissue tumors. 2, [14] [15] [16] These few reports have primarily focused on qualitative rather than quantitative analysis of DCE-MRI; thus, the results were subjective. The purpose of this study was to evaluate the potential of the semiquantitative and quantitative DCE-MRI parameters in the differential diagnosis of soft-tissue tumors.
Materials and Methods

Patients
This study was approved by the ethics committee of our hospital. Written informed consent was obtained before MRI examination from all patients. Medical records of 45 patients with pathologically confirmed (needle biopsy or surgery) softtissue tumors, from January 2017 to November 2018, were reviewed. Based on the World Health Organization pathological classification of soft-tissue tumors (2013), 17 all lesions were divided into benign or malignant tumor groups. The diagnosis of 15 benign tumors and 30 malignant tumors is listed in Tables 1 and 2, respectively. The soft-tissue tumor group included 22 men and 23 women (age range, 16-85 years; median age, 52 years).
Magnetic Resonance Imaging
The MRI examinations were conducted using a 3.0 T MRI scanner (MAGNETOM Skyra; Siemens Healthcare, Erlangen, Germany). Conventional MRI series (ie, axial, sagittal, and coronal spin-echo T1-weighted imaging [T1WI], T2-weighted imaging [T2WI], and fat-suppressed T2WI) were initially conducted to locate lesions and display the morphological characteristics. 
Data Analyses
Conventional MRI images were reviewed by 3 senior radiologists, who were unaware of the clinical and histopathological findings of the patients. The criteria for the evaluation of the tumors included the site, size, shape (circular or irregular), margin (well-defined or ill-defined), signal intensity (high, low, or intermediate), and enhancement pattern (mild or obvious). The signal intensity of the lesion was compared with that of the normal muscle tissue at the same level. Any differences of opinion were resolved by discussion. The DCE-MRI data were analyzed using noncommercial software packages (Omni-Kinetics; GE Healthcare, Chicago, Illinois). Preprocessing included motion correction, registration, and calculation of T1 maps. The DCE-MRI data analysis included semiquantitative and quantitative analyses. The semiquantitative parameters were as follows: time to peak (TTP), maximum concentration (MAX Conc), area under curve of the timeconcentration curve (AUC-TC), and maximum rise slope (MAX Slope). For the pharmacokinetic model of the quantitative DCE-MRI data, the arterial input function (AIF) was determined by direct measurement from a major artery within the image field of view (FOV) adjacent to the tumor. The DCE-MRI data set was subjected to pharmacokinetic analysis with the extended Tofts-Kety (ETK) model. Based on the conventional MRI features and enhancement pattern, the region of interest (ROI) was set in the solid parts of the lesion, while avoiding edema and the hemorrhagic necrotic parts. The ROI was used as the most enhanced solid region in the lesion. The ROIs covered areas of change between 1 and 5 cm 2 , based on the size of the solid parts of the lesion. Three ROIs were drawn 3 times by 3 senior radiologists, and the average value was calculated as the parameter value. The quantitative parameters were as follows: volume transfer constant (Ktrans), microvascular permeability reflux constant (Kep), extravascular extracellular space (EES) distribute volume per unit tissue volume (Ve). Figure 1 presents the workflow chart of the semiquantitative and quantitative analyses in DCE-MRI.
Statistical Analyses
The DCE-MRI data were statistically analyzed using SPSS (version 21.0; IBM, Chicago, Illinois). The values are expressed as mean + the standard deviation ( x þ s). The paired samples t test or Wilcoxon signed-rank test was adopted to the comparison between benign or malignant tumors and normal muscle tissue. The independent samples t test or Mann-Whitney U test was adopted to the comparison between benign and malignant tumors. A value of P < .05 indicated a significant difference. The multiple comparisons correction for P value adopted in this study was false discovery rate correction. For parameters with statistically significant differences, the receiver operating characteristic (ROC) curve was obtained.
Results
Conventional MRI
The characteristics of the patients and conventional MRI imaging features of the lesions are summarized in Table 3 . Forty-five soft-tissue tumor images were reviewed in this study. The time interval between MRI and needle biopsy or surgery is less than 7 days (time range, 1-7 days; mean time, 4.27 days). The lesions occurred in the trunk wall (n ¼ 1), upper extremity (n ¼ 3), and lower extremity (n ¼ 11) for benign soft-tissue tumors, and in the upper extremity (n ¼ 7) and lower extremity (n ¼ 23) for malignant soft-tissue tumors. The median sizes of the benign and malignant soft-tissue tumors were 3.1 and 6.25 cm, respectively. The shapes of the lesions were circular (n ¼ 13) and irregular (n ¼ 2) for the benign tumors and circular (n ¼ 19) and irregular (n ¼ 11) for the malignant tumors. The margins of the lesions were welldefined (n ¼ 14) and ill-defined (n ¼ 1) for the benign tumors and well-defined (n ¼ 12) and ill-defined (n ¼ 18) for malignant tumors. In benign and malignant tumors, most lesions were of low-signal intensity on T1WI and high-signal intensity on T2WI, and most benign tumors were homogeneous (n ¼ 11) and with mild enhancement (n ¼ 9), while most malignant tumors were heterogeneous (n ¼ 28) and with obvious enhancement (n ¼ 27).
Comparison Between Benign or Malignant Tumors and Normal Muscle Tissue
In benign tumors, there were significant differences between the benign lesion groups and control groups in TTP (P ¼ .041), MAX Conc (P < .001), AUC-TC (P < .001), MAX Slope (P < .001), Ktrans (P < .001), Kep (P < .001), and Ve (P < .001). The values of MAX Conc, AUC-TC, MAX Slope, Ktrans, Kep, and Ve were higher in the benign lesion groups than in the control groups. The values of TTP were higher in the benign lesion groups than in the control groups. In malignant tumors, there were significant differences between the malignant lesion groups and control groups in TTP (P < .001), MAX Conc (P < .001), AUC-TC (P < .001), MAX Slope (P < .001), Ktrans (P < .001), Kep (P < .001), and Ve (P < .001). The values of MAX Conc, AUC-TC, MAX Slope, Ktrans, Kep, and Ve were higher in the malignant lesion groups than in the control groups. The values of TTP were lower in the malignant lesion groups than in the control groups. Figure 2 shows a representative benign softtissue tumor (schwannoma), and Figure 3 shows a representative malignant soft-tissue tumor (alveolar soft part sarcoma).
Comparison Between Benign and Malignant Tumors
Statistical analyses of the quantitative and semiquantitative parameters for the benign and malignant lesions are presented in Table 4 . In the semiquantitative parameters, there were significant differences between benign and malignant soft-tissue tumors in TTP (P ¼ .0035), MAX Conc (P ¼ .0018), AUC-TC (P ¼ .0018), and MAX Slope (P ¼ .0018). The values of TTP were lower, while those of MAX Conc, AUC-TC, and MAX Slope were significantly higher in the malignant than in benign tumors. With respect to the quantitative parameters, there were significant differences between the benign and malignant softtissue tumors in terms of Ktrans (P ¼ .0018) and Kep (P ¼ .0035). The values of Ktrans and Kep were significantly higher in the malignant than in benign tumors. Additionally, the values of Ve were higher, although not significantly (P ¼ .1350), in the malignant than in benign tumors. There were no significant differences between the benign control groups and malignant control groups. 
Receiver Operating Characteristic Curves of the Benign and Malignant Soft-Tissue Tumors
Discussion
The concept of DCE-MRI was proposed in the mid-1980s as a method for measuring the contribution of tissue perfusion and capillary permeability to signal changes caused by the contrast agent. 18 Currently, DCE-MRI is an imaging tool for evaluating the microvascular environment of a tumor, and it shows promising potential for clinical applications such as tumor identification, characterization, and treatment response assessment. 16, 19 Our findings indicated that semiquantitative and quantitative parameters from DCE-MRI can provide the ability to differentiate between benign and malignant soft-tissue tumors. Of the several parameters, the MAX Conc was the most discriminating parameter in our study, with AUC-TC, MAX Slope, and Ktrans also showing a significant difference. Angiogenesis is an essential step in the pathophysiology of soft-tissue tumor growth. 20, 21 The vessels of normal tissue are intact, and the capillary bed tends to be mature. Stimulation from the microenvironment of soft-tissue tumor, such as hypoxia and weak acid, could increase the level of vascular endothelial growth factor (VEGF). 22 With VEGF stimulation, a soft-tissue tumor tends to generate a large number of tumor vessels. The tumor vascular structure is morphologically incomplete and lacks intact muscular and basal layers. 23 Owing to a high level of permeability, the reactivity and feeding capacity of tumor vessels are functionally low. 23 Therefore, microcirculation in the newly formed tumor is disorganized, and the fragile vessels are highly permeable. The kinetics of the contrast agent transit depends heavily on tissue perfusion, vessel permeability, and volume of the EES. 4 Biological behaviors and microcirculation characteristics vary in benign and malignant soft-tissue tumors, which result in differences in the pharmacokinetic distributions of the contrast agent. Dynamic contrast-enhanced MRI aids in differentiation of these pharmacokinetic distributions and can enable conversion of the distributions into objective parameters. 24 Based on the literature reports, DCE-MRI analysis can be divided into 3 types: qualitative, semiquantitative, and quantitative. 4, 18 Qualitative analysis is the basic analysis of DCE-MRI. It is based on the subjective evaluation of the time-signal intensity curve (TIC) to determine the inflow rate and clearance time of the contrast agent into the lesion. 25 Furthermore, it can help determine the degree of enhancement and blood supply characteristics of the lesion. 25 This approach is intuitive but is prone to errors due to technical expertise requirement and bias introduction; thus, the results of a qualitative analysis are subjective. 4, 26 It also does not provide quantifiable parameters (eg, the rate of tracer uptake or washout) or measurements of tissue perfusion and permeability. 4 Therefore, a qualitative analysis with DCE-MRI was not performed in this study.
This study focused on 2 other DCE-MRI analyses: semiquantitative and quantitative. Semiquantitative analysis can be used to calculate semiquantitative parameters based on the morphological characteristics of the TIC. It does not require the assistance of pharmacokinetic models. In this study, the semiquantitative parameters were obtained automatically using Omni-Kinetic software and are defined as follows: TTP is the time between the onset of a positive enhancement and the peak value of the time curve; the MAX Conc is the maximum concentration (ie, peak enhancement) of the time-varying TIC; the AUC-TC is the area under the TIC; and the MAX Slope is the maximum slope of the rise line in TIC. In this study, the values of TTP were significantly lower, while those of MAX Conc, AUC-TC, and MAX Slope were significantly higher in the malignant than in benign tumors.
Malignant soft-tissue tumors have high vascularity and narrow interstitial space. 7 Most malignant tumors show rapid and high-contrast enhancement. However, benign tumors, owing to their slow perfusion and their wider interstitial space, nearly always show late contrast enhancement. 2, 7 Several studies have also found that malignant lesions tended to show higher early rapid enhancement. 2 In the early stage of dynamic enhancement, the contrast agent enters the vessel of the tumor. An increased number of capillaries and high level of blood perfusion can increase the signal in the tumor. In the late stage of dynamic enhancement, the contrast agent diffuses into the extravascular space and can cause a signal change in the tumor. To a certain extent, semiquantitative parameters can reflect these pharmacokinetic distributions in the tumor. 5 Notably, semiquantitative analysis is influenced by the scanning conditions. 5, 27 It is difficult to estimate the intrinsic physiologic features of a tumor such as vascular permeability and blood flow. 26, 28 Evaluation of the intrinsic physiologic features of a tumor should rely on quantitative analysis. Quantitative analysis with the DCE-MRI should provide the AIF of the lesion, which reflects the changes in the contrast agent concentration that occur over time in a blood vessel feeding a tissue of interest. 29 In this study, the AIF was determined by direct measurement from a major artery within the image in the FOV adjacent to the tumor. Quantitative analysis with the DCE-MRI will also require the assistance of different pharmacokinetic models. An appropriate model would be consistent with the distribution pattern of the contrast agent in the lesion and able to obtain more accurate parameters. 30 In this study, the DCE-MRI data set was subjected to pharmacokinetic analysis with the ETK model, which is valid for 2 tissue types: highly perfused tissues and weakly vascularized tissues with a well-mixed interstitium. 18 The ETK model divides the tissue into 2 parts: the tissue blood plasma and the interstitium. 18 The interstitium is also called the EES. The contrast agent exchange between both the spaces is by its leakage across the endothelial wall, which is assumed to be the same in both directions. 18 The critical measure of tissue function is the rate at which nutrients are delivered to the interstitial space. This important physiological parameter is the Ktrans. 18 It is defined explicitly as the number of indicator particles that are delivered to the interstitium, per unit of time, tissue volume, and arterial plasma concentration; Kep is the rate constant between the interstitium and plasma. As the perfusion parameters, Ktrans and Kep are related to the blood flow volume of a tissue and the permeability of blood capillaries. 20 Our results indicated that the Ktrans and Kep values were significantly higher in the malignant than in benign soft-tissue tumors. The Ktrans and Kep values in the malignant lesions may be higher because the soft-tissue tumor cells are more proliferative. 22, 31 With the increasing malignancy of softtissue tumors, the ability of tumor vessel generation becomes stronger. The tumor vessel has a high level of permeability, which results in a high level of perfusion and permeability in the microcirculation and ultimately results in the higher Ktrans and Kep values in malignant lesions. The finding that malignant tumors had higher Ktrans and Kep values was consistent with the findings of previous studies showing higher Ktrans and Kep values in malignant tumors in breast cancer, 8, 9 glioma, 10,11 and prostate cancer. 12, 13 In addition to Ktrans and Kep, the Ve value may have a complementary role in the differential diagnosis of soft-tissue tumors. The Ve value reflects the EES, which is restricted by vessel walls and cell plasma membranes because the interstitial fluid and connective tissue are arranged in a supportive frame structure. In this study, the Ve values were higher in the malignant tumors than in benign tumors. However, the differences were not statistically significant. Some studies have demonstrated that Ve values can increase or decrease as the malignancy of the tumor increases, and that the Ve is unstable because of edema around lesions. 2, 10 However, further studies are needed to determine the values of Ve that are as important as those of Ktrans and Kep in the differential diagnosis of softtissue tumors.
Several practical limitations of this study must be addressed. Only 45 patients with pathologically confirmed soft-tissue tumors were retrospectively reviewed because of the low incidence of these tumors. The small number of cases may not adequately represent the wide range of benign and malignant soft-tissue tumors. The vascular tumors have a high level of vascular components, which may affect the level of perfusion and permeability in the microcirculation and ultimately affect the values of parameters. So, it is unclear whether it was appropriate to include vascular tumors such as hemangioma in the benign group.
Conclusion
The preliminary findings suggested that semiquantitative and quantitative parameters of DCE-MRI enabled differentiation between benign and malignant soft-tissue tumors. The values of TTP were lower, while those of MAX Conc, AUC-TC, and MAX Slope were higher, for malignant soft-tissue tumors than for benign tumors. The values of Ve in the differentiation of benign and malignant soft-tissue tumors remain to be further studied.
